| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |